Anticancer agent 129

• Description :

  Anticancer agent 129 (Compound 3a), a quinoline derivative, predicting to has anti-cancer activity[1].

• Product Name Alternative :

  UR-8880

• UNSPSC :

  12352005

• Target :

  Drug Derivative

• Type :

  Reference compound

• Related Pathways :

  Others

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/anticancer-agent-129.html

• Purity :

  99.01

• Solubility :

  DMSO : 125 mg/mL (ultrasonic)

• Smiles :

  NC1=C2C(N(CC3=CC=CC=C3)CC2)=NC4=CC=CC=C14

• Molecular Formula :

  C18H17N3

• Molecular Weight :

  275.35

• References & Citations :

  [1]Vaidya A, et al. Predicting anti-cancer activity of quinoline derivatives: CoMFA and CoMSIA approach. J Enzyme Inhib Med Chem. 2011 Dec;26 (6) :854-61.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [135882-37-0]